drugset / Trial / NCT04557878
Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction
RandomizedParallel-groupDouble-blindTreatment
Summary
Purpose of the study is to compare clinically, radiographically and biochemically the effect of intra- articular injection of hypertonic dextrose with a stabilization appliance and the intra- articular injection of 2 ml of liquid phase concentrated growth factor with a stabilization appliance as a prolotherapy for temporomandibular joint anterior disc displacement without reduction.
Timeline
- Start
- 2020-10-06
- Primary completion
- 2021-04-01
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextrose | Unknown | 12.5 % | Other |
| Comparator | Liquid Phase Concentrated Growth Factor | Unknown | 2 ml | Other |